MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-06-0035643
Litex Pharmaceuticals Private Limited
Litex Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹8.43 Cr
▲ 18% YoY
Net profit · FY 2024
₹13.56 Lakh
Net margin 1.6%
EBITDA · FY 2024
₹21.93 Lakh
EBITDA margin 2.6%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Secured borrowings
Company age
38 yrs
Est. 1988
Directors on board
2
As per MCA filings
About Litex Pharmaceuticals Private Limited
Data last updated:
Litex Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 February 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1988PTC030484. Its GSTIN is 07AAACL0180D1Z2 (Delhi).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Kusum Thakur and Ajay Thakur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 1 Mezanine Floor Commercial Complex Nimri Colony Ashok Vihar Phase – 4, Delhi, India – 110052.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.43 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹13.56 Lakh (net margin 1.6%) and EBITDA of ₹21.93 Lakh (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 12% over five years.
As per MCA filings, the company has open charges of ₹50 Lakh on record. Court records list 4 cases involving the company, including 4 filed by the company; 1 case is pending.
Litex Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0035643). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74899DL1988PTC030484
Registration Number 030484
Incorporation Date 02 February 1988
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-06-0035643
Key People
Kusum Thakur Director Ajay Thakur Director Recognitions & Rankings of Litex Pharmaceuticals
Contact details
Litex Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 1 Mezanine Floor Commercial Complex Nimri Colony Ashok Vihar Phase – 4, Delhi, India – 110052
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Litex Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Litex Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Litex Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Litex Pharmaceuticals Private Limited, buy the company report.
Financials of Litex Pharmaceuticals Private Limited
FY 2025 filings availableLitex Pharmaceuticals Private Limited reported revenue of ₹8.43 Cr (up 18% YoY) for FY 2024.
Revenue · FY 2024
₹8.43 Cr ▲ 18%
Net profit · FY 2024
₹13.56 Lakh margin 1.6%
EBITDA · FY 2024
₹21.93 Lakh margin 2.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 19%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 39%
5 years · compounded
▲ 26%
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 18% growth in the latest year. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.93 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Litex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Litex Pharmaceuticals Private Limited
Litex Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kusum Thakur | Director | 17 Feb 2020 | 6 Years 8 Months | Current |
| Ajay Thakur | Director | 01 Apr 2000 | 26 Years 6 Months | Current |
Peer comparison
Litex Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aggarwal Medical Store Private Limited | ₹8.44 Cr (FY 2024) | -1.0% | New Delhi, Delhi, India | |||
| Alaric Healthcare Private Limited | ₹8.44 Cr (FY 2017) | 116.0% | Yamuna Nagar, Haryana, India | |||
| Neomac Pharmaceuticals Private Limited | ₹8.43 Cr (FY 2024) | 21.0% | Amritsar, Punjab, India | |||
| Litex Pharmaceuticals Private Limitedthis company | ₹8.43 Cr (FY 2024) | ₹13.56 Lakh | 1.6% | 18.0% | Delhi, India | |
| Watran Pharmaceuticals Private Limited | ₹8.42 Cr (FY 2025) | 24.0% | Ambala, Haryana, India | |||
| Hindustan Trust Private Limited | ₹8.42 Cr (FY 2025) | 5.0% | Delhi, India | |||
| Herbs and Health Makers (India) Private Limited | ₹8.38 Cr (FY 2025) | 1.0% | Indore, Madhya Pradesh, India | |||
| Integron Pharma Private Limited | ₹8.36 Cr (FY 2024) | 17.0% | Thrissur, Kerala, India |
To see the full peer comparison of Litex Pharmaceuticals Private Limited, buy the company report.
Auditor
Litex Pharmaceuticals Private Limited is audited by BHAGWANT SINGH & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHAGWANT SINGH & CO. | FY 2022 | 092226 |
Shareholding
The shareholding of Litex Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Litex Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹50 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jan 2024 | 100853176 | Others | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Litex Pharmaceuticals Private Limited has 4 court cases on record: 4 filed by Litex Pharmaceuticals. 1 case is pending and 3 are disposed.
Total cases
4
Filed by the company
4
Pending
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, West, Delhi | Criminal case | Filed by the company against Ashu Enterprises | Disposed |
| District court, North West, Delhi | Court case (EX CIVIL) | Filed by the company against M/S Nilsan Pharmaceutic Als Pvt. Ltd. | Disposed |
| District court, North West, Delhi | Civil suit | Filed by the company against Ms Nilsan Pharmaceutical Pvt. Ltd. | Disposed |
To see the full case history of Litex Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Litex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Litex Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACL0180D1Z2 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Litex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Litex Pharmaceuticals Private Limited has 3 board changes on record since 2000: 2 appointments and 1 cessation. The latest: Amit Vijay ceased to be Director on 02 Mar 2020.
AGM
Litex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Litex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 100853176 was registered on 08 Jan 2024.
Ceased
Amit Vijay ceased to be Director.
Appointed
Kusum Thakur was appointed as Director.
Appointed
Ajay Thakur was appointed as Director.
Incorporation
02 Feb 1988
Litex Pharmaceuticals Private Limited was registered on 02 Feb 1988 with Roc Delhi & aged 38 years 8 months as per MCA records.
Frequently asked questions
Litex Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 February 1988 (38+ years old) and is registered under CIN U74899DL1988PTC030484.
Litex Pharmaceuticals has 2 current directors:
- Kusum Thakur - Director
- Ajay Thakur - Director
The latest financial statements of Litex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Litex Pharmaceuticals is 07AAACL0180D1Z2, registered in Delhi.
The CIN (Corporate Identification Number) of Litex Pharmaceuticals is U74899DL1988PTC030484. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Litex Pharmaceuticals has 4 court cases on record: 4 filed by the company. 1 is pending.
Litex Pharmaceuticals was incorporated on 02 February 1988, making it 38+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Litex Pharmaceuticals by revenue are Aggarwal Medical Store Private Limited, Alaric Healthcare Private Limited, Neomac Pharmaceuticals Private Limited, Watran Pharmaceuticals Private Limited, Hindustan Trust Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Amit Vijay ceased to be Director on 02 Mar 2020. Kusum Thakur was appointed as Director on 17 Feb 2020. Ajay Thakur was appointed as Director on 01 Apr 2000.
Yes, Litex Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-06-0035643).
The registered office of Litex Pharmaceuticals is at A – 1 Mezanine Floor Commercial Complex Nimri Colony Ashok Vihar Phase – 4, Delhi, India – 110052.